How Biotechs Survive the Valley of Death

Follow us on LinkedIn (https://www.linkedin.com/company/biotechnology-innovation-organization/posts/?feedView=all) , X (https://twitter.com/IAmBiotech) , Facebook (https://www.facebook.com/IAmBiotech/) and Instagram (https://www.instagram.com/iambiotech/) . 

Visit us at https://www.bio.org/

For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It’s a treacherous journey—one that even promising innovations often don’t complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry. 

source